glutathione approved by fda DOH warns against use of intravenous list of fda-approved glutathione 2019

Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H,

He had an absorbtion problem

Subcutaneous injections deliver consistently, can be administered on the patients schedule, and dont require a clinic visit each time

AOD is intended exclusively for laboratory research purposes

Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K

The primary antibodies used were anti- VEGF-A (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- VEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- pVEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- AKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- pAKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- ERK (Cell Signaling Technology, Berkeley, CA, USA), anti- pERK (Cell SignalingT echnology, Berkeley, CA, USA), anti- p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- p-p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- eNOS (Proteintech, Chicago, IL, USA), anti- p-eNOS (Proteintech, Chicago, IL, USA), anti- CHOP (Cell Signaling Technology, Berkeley, CA, USA) and anti- -actin (Cell Signaling Technology, Berkeley, CA, USA)